Continental Resources, Inc.:企業の戦略・SWOT・財務情報

◆英語タイトル:Continental Resources, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C1836
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:44
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:石油・ガス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Continental Resources, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Continental Resources, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Continental Resources, Inc. (Continental or ‘the company’) is an independent crude oil and natural gas exploration and production company. It primarily operates in the North, South and East regions of the US. Its north region consists of properties north of Kansas and west of the Mississippi River. It also includes North Dakota Bakken, Montana Bakken, and the Red River units. The South region comprises properties south of Nebraska and west of the Mississippi River including South Central Oklahoma oil province, sooner trend Anadarko Canadian Kingfisher and Arkoma Woodford areas of Oklahoma. The company is headquartered in Oklahoma City, Oklahoma, US.

Scope

- Detailed information on Continental Resources, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Continental Resources, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Continental Resources, Inc. including a breakdown and examination of key business segments
- Intelligence on Continental Resources, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Continental Resources, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Continental Resources, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Continental Resources, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Continental Resources, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Continental Resources, Inc.: Company Overview 9
Continental Resources, Inc.: Overview and Key Facts 9
Continental Resources, Inc.: Overview 9
Continental Resources, Inc.: Key Facts 9
Continental Resources, Inc.: Key Employees 11
Continental Resources, Inc.: Key Employee Biographies 13
Continental Resources, Inc.: Major Products and Services 15
Continental Resources, Inc.: Company History 16
Continental Resources, Inc.: Management Statement 18
Continental Resources, Inc.: Key Competitors 21
Continental Resources, Inc.: Company Analysis 22
Continental Resources, Inc.: Business Description 22
Continental Resources, Inc.: SWOT Analysis 23
Continental Resources, Inc.: SWOT Overview 23
Continental Resources, Inc.: Strengths 23
Continental Resources, Inc.: Weaknesses 24
Continental Resources, Inc.: Opportunities 24
Continental Resources, Inc.: Threats 24
Continental Resources, Inc.: Corporate Financial Deals Activity 27
Continental Resources, Inc.: Financial Deals Overview 27
Continental Resources, Inc.: Targets and Partners 29
Continental Resources, Inc.: Top Deals 2014 – 2018YTD* 30
Continental Resources, Inc.: Capital Raising 31
Continental Resources, Inc.: Partnership 32
Continental Resources, Inc.: Divestments 33
Continental Resources, Inc.: Recent Developments 34
Continental Resources, Inc.: News and Events Summary 34
Continental Resources, Inc.: Contracts 37
Continental Resources, Inc.: Corporate Governance 39
Continental Resources, Inc.: Financial Performance 39
Continental Resources, Inc.: Regulatory and Legal Events 39
Continental Resources, Inc.: Strategy and Operations 40
Appendix 42
Contact Us 42
Methodology 42
About MarketLine 43

List of Tables
Table 1: Continental Resources, Inc.: Key Facts
Table 2: Continental Resources, Inc.: Key Employees
Table 3: Continental Resources, Inc.: Key Competitors
Table 4: Continental Resources, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 5: Continental Resources, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 6: Continental Resources, Inc.: Targets and Partners
Table 7: Continental Resources, Inc.: Top Deals 2014 - 2018YTD*
Table 8: Continental Resources, Inc.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 9: Continental Resources, Inc.: Capital Raising by Deal Type (2014 - YTD*2018)
Table 10: Continental Resources, Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 11: Continental Resources, Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 12: Continental Resources, Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 13: Continental Resources, Inc.: News and Events Summary
Table 14: Continental Resources, Inc.: Contracts
Table 15: Continental Resources, Inc.: Corporate Governance
Table 16: Continental Resources, Inc.: Financial Performance
Table 17: Continental Resources, Inc.: Regulatory and Legal Events
Table 18: Continental Resources, Inc.: Strategy and Operations

List of Figures
Figure 1: Continental Resources, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Continental Resources, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Continental Resources, Inc.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 4: Continental Resources, Inc.: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 5: Continental Resources, Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 6: Continental Resources, Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 7: Continental Resources, Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)

★海外企業調査レポート[Continental Resources, Inc.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Century Insurance Company Limited:企業の戦略・SWOT・財務情報
    Century Insurance Company Limited - Strategy, SWOT and Corporate Finance Report Summary Century Insurance Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Spectral Medical Inc (EDT):製薬・医療:M&Aディール及び事業提携情報
    Summary Spectral Medical Inc (Spectral), formerly Spectral Diagnostics Inc, is a biotechnology company that develops and commercializes diagnostic solutions for patient management. The company’s products comprise EAA, toraymyxin and reagents, among others. Its EAA is an endotoxin activity assay, whi …
  • Zymeworks Inc:企業のM&A・事業提携・投資動向
    Zymeworks Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Zymeworks Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • AMAG Pharmaceuticals Inc (AMAG)-医療機器分野:企業M&A・提携分析
    Summary AMAG Pharmaceuticals Inc (AMAG) is a biopharmaceutical company that develops and commercializes specialty pharmaceutical products. The company focuses on maternal health, anemia management and cancer supportive care. Its major products include Makena (hydroxyprogesterone caproate injection) …
  • Adaptimmune Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Adaptimmune Ltd (Adaptimmune), a subsidiary of Adaptimmune Therapeutics Plc is a clinical stage biotechnology company that develops T-cell therapy products for the treatment of cancer. The company’s pipeline peptides include NY-ESO TCR used to treat cancer cells, MAGE A-10 TCR used for the t …
  • SciBase AB (SCIB):企業の財務・戦略的SWOT分析
    Summary SciBase AB (SciBase) is a medical technology company that offers non-invasive detection and monitoring of skin tissue alterations. The company develops point of care device for the accurate detection of malignant melanoma. It offers electrical impedance spectroscopy which uses the varying el …
  • Burmeister & Wain Scandinavian Contractor AS-エネルギー分野:企業M&A・提携分析
    Summary Burmeister & Wain Scandinavian Contractor A/S (BWSC), a subsidiary of MESCO Denmark A/S, is a provider of tailor-made turnkey power plant solutions. It develops, operates and undertakes contracts for medium to large-scale power plants. The company handles projects for conventional fossil-fue …
  • Quebecor Inc (QBR.B):企業の財務・戦略的SWOT分析
    Quebecor Inc (QBR.B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Koninklijke Philips N.V.:企業のM&A・事業提携・投資動向
    Koninklijke Philips N.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Koninklijke Philips N.V. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Immunomedics Inc (IMMU):製薬・医療:M&Aディール及び事業提携情報
    Summary Immunomedics Inc (Immunomedics) is a clinical-stage bio-pharmaceutical company that researches, develops, manufactures and commercializes monoclonal antibody-based drugs for the treatment of cancer and autoimmune disorders. The company develops its candidates based on its proprietary technol …
  • Nuclear Decommissioning Authority:企業の戦略的SWOT分析
    Nuclear Decommissioning Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Tuesday Morning Corporation (TUES):企業の財務・戦略的SWOT分析
    Tuesday Morning Corporation (TUES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Jamaica Public Service Co Ltd:企業の戦略的SWOT分析
    Jamaica Public Service Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Synedgen Inc:医療機器:M&Aディール及び事業提携情報
    Summary Synedgen Inc (Synedgen) is a biotechnology company that discovers and develops polysaccharide-based drugs, which enhance and mimic the innate immune system. The company’s pipeline products include SYGN305, SYGN399, SYGN303, SYGN313 and SYGN309. Synedgen develops products for the treatment of …
  • Nobilis Health Corp (NHC):企業の財務・戦略的SWOT分析
    Summary Nobilis Health Corp (Nobilis Health), formerly Northstar Healthcare Inc is a healthcare development and management company that offers outpatient surgery and healthcare solutions. The center’s services include surgical services, surgery and critical patient education services. Its surgical s …
  • Transplant Genomics Inc:企業の製品パイプライン分析2018
    Summary Transplant Genomics Inc (TGI) is a biotech company. The company carries out performing organ transplantation using non-invasive serial monitoring under the guidance of genomics. It aims in detecting early signs of graft injury by conducting molecular diagnostic tests, enabling in differentia …
  • Cantargia AB (CANTA):企業の財務・戦略的SWOT分析
    Summary Cantargia AB (Cantargia), a subsidiary of Lund University Bioscience AB is a biotechnology company that develops antibody based cancer treatments. The company’s product candidate CAN04 is used for the treatment of cancers including non-small cell lung cancer and pancreatic cancer. It utilize …
  • Proteome Sciences Plc (PRM):企業の製品パイプライン分析
    Summary Proteome Sciences Plc (Proteome Sciences) is a life sciences company that delivers content for personalized medicine through biomarkers, reagents and services. Its proteomics services include drug development, biomarker discovery, quality management and provision of data insights. The compan …
  • Medidata Solutions Inc (MDSO)-製薬・医療分野:企業M&A・提携分析
    Summary Medidata Solutions Inc (Medidata) is a provider of cloud based solutions for life sciences sectors. It offers wide range of advanced tools for data & analytics, planning, data capture, study management, monitoring, payments, and platform services. The company offers technology and data analy …
  • Sensimed AG-医療機器分野:企業M&A・提携分析
    Summary Sensimed AG (Sensimed) is a medical device company that offers soft contact lens-based solutions. The company’s products comprise Sensimed Triggerfish, a non-invasive soft contact lens-based solution designed for the overall management of glaucoma. It offers automated recording of continuous …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆